Qilian International Holding Group Ltd

$BGM Market Cap: $31.57 Million

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$111.3M

TTM

Gross Margin

5.98%

TTM

Net Earnings

-$6.704M

TTM

Current Assets

$34.51M

Q3 2023

Current Liabilities

$6.660M

Q3 2023

Current Ratio

518.2%

Q3 2023

Total Assets

$51.26M

Q3 2023

Total Liabilities

$6.907M

Q3 2023

Book Value

$44.35M

Q3 2023

Cash

$7.476M

Q3 2023

P/E

-4.708

Nov 13, 2024 EST

Free Cash Flow

$14.78M

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019	2018	2017
Revenue	$46.47M	$64.86M	$57.10M	$50.03M	$46.10M	$50.37M	$22.54M
YoY Change	-28.35%	13.58%	14.13%	8.52%	-8.48%	123.47%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019	2018	2017
Revenue	$46.47M	$64.86M	$57.10M	$50.03M	$46.10M	$50.37M	$22.54M
Cost Of Revenue	$44.72M	$58.63M	$51.46M	$42.49M	$36.42M	$42.24M	$19.16M
Gross Profit	$1.751M	$6.227M	$5.639M	$7.540M	$9.680M	$8.130M	$3.380M
Gross Profit Margin	3.77%	9.6%	9.87%	15.07%	21.0%	16.14%	15.0%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019	2018	2017
Selling, General & Admin	$3.793M	$4.125M	$3.242M	$2.670M	$3.460M	$1.990M	$2.170M
YoY Change	-8.05%	27.23%	21.44%	-22.83%	73.87%	-8.29%
% of Gross Profit	216.57%	66.25%	57.51%	35.41%	35.74%	24.48%	64.2%
Research & Development	$568.5K	$1.224M	$8.000K	$50.00K	$40.00K	$170.0K	$80.00K
YoY Change	-53.57%	15204.3%	-84.0%	25.0%	-76.47%	112.5%
% of Gross Profit	32.46%	19.66%	0.14%	0.66%	0.41%	2.09%	2.37%
Depreciation & Amortization	$1.143M	$1.225M	$1.201M	$1.110M	$1.190M	$1.250M	$1.240M
YoY Change	-6.66%	1.95%	8.22%	-6.72%	-4.8%	0.81%
% of Gross Profit	65.26%	19.67%	21.3%	14.72%	12.29%	15.38%	36.69%
Operating Expenses	$4.362M	$5.350M	$3.250M	$2.730M	$3.500M	$2.160M	$2.250M
YoY Change	-18.47%	64.58%	19.07%	-22.0%	62.04%	-4.0%
Operating Profit	-$2.610M	$2.102M	$2.388M	$4.810M	$6.180M	$5.970M	$1.130M
YoY Change	-224.17%	-11.98%	-50.35%	-22.17%	3.52%	428.32%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020	2019	2018	2017
Interest Expense	-$5.424M	-$787.9K	$404.3K	-$240.0K	-$220.0K	-$220.0K	-$280.0K
YoY Change	588.4%	-294.87%	-268.48%	9.09%	0.0%	-21.43%
% of Operating Profit		-37.49%	16.93%	-4.99%	-3.56%	-3.69%	-24.78%
Other Income/Expense, Net	-$5.293M	-$541.4K	$570.9K	$1.240M	$990.0K	$390.0K	$1.010M
YoY Change	877.54%	-194.84%	-53.96%	25.25%	153.85%	-61.39%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019	2018	2017
Pretax Income	-$7.903M	$1.561M	$3.363M	$5.810M	$6.940M	$6.150M	$1.860M
YoY Change	-606.41%	-53.6%	-42.11%	-16.28%	12.85%	230.65%
Income Tax	$219.2K	$194.3K	$255.1K	$860.0K	$1.030M	$940.0K	$320.0K
% Of Pretax Income		12.45%	7.59%	14.8%	14.84%	15.28%	17.2%
Net Earnings	-$7.781M	$1.077M	$3.153M	$5.060M	$5.330M	$5.170M	$1.410M
YoY Change	-822.64%	-65.85%	-37.69%	-5.07%	3.09%	266.67%
Net Earnings / Revenue	-16.74%	1.66%	5.52%	10.11%	11.56%	10.26%	6.26%
Basic Earnings Per Share	-$0.22	$0.03	$0.09	$0.17
Diluted Earnings Per Share	-$0.22	$0.03	$92.49K	$144.6K	$152.3K	$147.7K	$40.29K

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2019	2018	2017
Cash & Short-Term Investments	$22.42M	$14.32M	$10.47M	$11.87M	$4.590M	$5.260M	$5.370M
YoY Change	56.57%	36.8%	-11.82%	158.61%	-12.74%	-2.05%
Cash & Equivalents
Short-Term Investments	$14.94M
Other Short-Term Assets	$747.3K	$1.964M	$3.932M	$1.020M	$1.710M	$2.030M	$2.720M
YoY Change	-61.94%	-50.07%	285.54%	-40.35%	-15.76%	-25.37%
Inventory	$4.991M	$8.879M	$12.50M	$11.99M	$12.52M	$9.590M	$12.85M
Prepaid Expenses
Receivables	$1.976M	$815.3K	$1.733M	$1.120M	$600.0K	$1.330M	$320.0K
Other Receivables	$4.379M	$4.056M	$11.74M	$11.51M	$5.540M	$3.960M	$690.0K
Total Short-Term Assets	$34.51M	$30.03M	$40.37M	$37.52M	$24.97M	$22.17M	$21.96M
YoY Change	14.91%	-25.59%	7.58%	50.26%	12.63%	0.96%
Property, Plant & Equipment	$12.07M	$10.27M	$9.238M	$7.660M	$7.670M	$8.490M	$8.840M
YoY Change	17.53%	11.18%	20.6%	-0.13%	-9.66%	-3.96%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$606.0K	$20.09M	$20.96M	$540.0K	$540.0K	$410.0K	$160.0K
YoY Change	-96.98%	-4.17%	3782.01%	0.0%	31.71%	156.25%
Other Assets	$645.2K	$2.407M	$2.860M	$540.0K	$260.0K	$320.0K	$340.0K
YoY Change	-73.2%	-15.82%	429.57%	107.69%	-18.75%	-5.88%
Total Long-Term Assets	$16.75M	$34.49M	$34.99M	$10.62M	$10.30M	$11.17M	$11.42M
YoY Change	-51.45%	-1.42%	229.45%	3.11%	-7.79%	-2.19%
Total Assets	$51.26M	$64.53M	$75.35M	$48.14M	$35.27M	$33.34M	$33.38M
YoY Change
Accounts Payable	$4.798M	$5.991M	$6.644M	$4.380M	$3.570M	$3.760M	$4.690M
YoY Change	-19.91%	-9.83%	51.68%	22.69%	-5.05%	-19.83%
Accrued Expenses	$73.56K	$23.86K	$55.85K	$80.00K
YoY Change	208.3%	-57.28%	-30.19%
Deferred Revenue
YoY Change
Short-Term Debt	$479.7K	$1.672M	$7.867M	$7.350M	$4.900M	$4.220M	$6.940M
YoY Change	-71.31%	-78.74%	7.03%	50.0%	16.11%	-39.19%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$6.660M	$9.181M	$18.17M	$18.42M	$11.66M	$14.29M	$17.97M
YoY Change	-27.45%	-49.49%	-1.33%	57.98%	-18.4%	-20.48%
Long-Term Debt	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$246.5K	$382.5K	$509.9K	$880.0K	$970.0K	$1.330M	$1.760M
YoY Change	-35.57%	-24.99%	-42.05%	-9.28%	-27.07%	-24.43%
Total Long-Term Liabilities	$246.5K	$382.5K	$509.9K	$880.0K	$970.0K	$1.330M	$1.760M
YoY Change	-35.57%	-24.99%	-42.05%	-9.28%	-27.07%	-24.43%
Total Liabilities	$8.466M	$11.47M	$20.49M	$22.04M	$15.37M	$18.02M	$22.14M
YoY Change	-26.22%	-44.01%	-7.01%	43.4%	-14.71%	-18.61%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021	2020
Basic Shares Outstanding	35.75M	35.75M	34.09M	30.00M
Diluted Shares Outstanding	35.75M	35.75M	34.09M	30.00M
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $31.565 Million

About Qilian International Holding Group Ltd

Qilian International Holding Group Ltd is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Jiuquan, Gansu and currently employs 298 full-time employees. The company went IPO on 2021-01-12. Qilian International Holding Group Ltd is a China-based company mainly engaged in the development, manufacture, marketing and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives (TCMD) product, heparin product, sausage casings and fertilizers. The firm operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. Its main brand is Qilian Shan. The firm principally operates its businesses within the domestic market.

Industry: Pharmaceutical Preparations Peers: China Pharma Holdings Inc China SXT Pharmaceuticals Inc SUNWIN STEVIA INTERNATIONAL, INC. Universe Pharmaceuticals Inc